Topokine Therapeutics' Acquisition

Topokine Therapeutics was acquired by Allergan on April 22, 2016.

Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin cream being developed for l…

Articles about Topokine Therapeutics' Acquisition: